Májzsugor, máj regenerálódása

Publikációk neves kutatóintézetektől

1.

Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma.

Nagai H, Mukozu T, Matsui D, Kanekawa T, Kanayama M, Wakui N, Momiyama K, Shinohara M, Iida K, Ishii K, Igarashi Y, Sumino Y.

Clin Dev Immunol. 2012;2012:607851. doi: 10.1155/2012/607851. Epub 2012 May 14.

PMID: 22666283

2.

Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.

Momiyama K, Nagai H, Sumino Y.

Cancer Chemother Pharmacol. 2009 Jul;64(2):271-7. doi: 10.1007/s00280-008-0866-8. Epub 2008 Nov 15.

PMID: 19011857

3.

Effect of Active Hexose Correlated Compound (AHCC) in alcohol-induced liver enzyme elevation.

Kim H, Kim JH, Im JA.

J Nutr Sci Vitaminol (Tokyo). 2014;60(5):348-56. doi: 10.3177/jnsv.60.348.

PMID: 25744424 Free Article

4.

Effect of active hexose correlated compound on the production of nitric oxide in hepatocytes.

Matsui K, Kawaguchi Y, Ozaki T, Tokuhara K, Tanaka H, Kaibori M, Matsui Y, Kamiyama Y, Wakame K, Miura T, Nishizawa M, Okumura T.

JPEN J Parenter Enteral Nutr. 2007 Sep-Oct;31(5):373-80; discussion 380-1.

PMID: 17712145